RT Journal Article
SR Electronic
T1 661 Dipeptidyl peptidase-9 (DPP9) overexpression is a potential response-predictive biomarker of BXCL701 and pembrolizumab combination treatment in mCRPC patients with SCNC phenotype
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A753
OP A753
DO 10.1136/jitc-2023-SITC2023.0661
VO 11
IS Suppl 1
A1 Donkor, Moses K
A1 Agarwal, Veena
A1 Kupchick, Sherry
A1 Deshpande, Rashmi
A1 Newmin, Dawn
A1 O’Neill, Vincent
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A753.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.